Célèste Lebbé

Researcher Next ID · RN-002246

Researcher · Biochemistry, Genetics and Molecular Biology

Paris, France

Not currently recruitingFunding unknown

Research interests

Biochemistry, Genetics and Molecular Biology

Medicine

Immunology and Microbiology

Melanoma and MAPK Pathways

Cancer Immunotherapy and Biomarkers

Cutaneous Melanoma Detection and Management

CAR-T cell therapy research

Immunotherapy and Immune Responses

Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
New England Journal of Medicine · 2017 · https://doi.org/10.1056/nejmoa1709684
Nivolumab in Previously Untreated Melanoma without BRAF Mutation
New England Journal of Medicine · 2014 · https://doi.org/10.1056/nejmoa1412082
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
New England Journal of Medicine · 2011 · https://doi.org/10.1056/nejmoa1103782
Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
New England Journal of Medicine · 2011 · https://doi.org/10.1056/nejmoa1104621
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
New England Journal of Medicine · 2010 · https://doi.org/10.1056/nejmoa1003466

No projects listed.